Mr. Speaker, after weeks of delaying getting the Canadian-made Ebola vaccine to Africa, a prominent Canadian expert is calling on the Conservative government to cancel its licensing agreement with the American company contracted to continue development of the vaccine. He says that this small U.S. company just does not have the resources to manage such an urgently needed medicine.
Can the government confirm reports that the licence for this vaccine was sold for just $200,000? What action is the government taking to make sure this vaccine is in the hands of a company capable of getting it to those who so desperately need it right away?